Support for FY 2024 funding of: $738 million for the Childrens Hospital Graduate Medical Education (CHGME) Program; and strong funding levels for Healthy Start, Pediatric Specialty Loan Repayment Program; pediatric research at the NIH; CDC & NIH gun violence prevention research, and the Child Abuse Prevention and Treatment Act. Support for FY2025 of: $758 million for CHGME; $865,000 in community directed spending for Childrens Laboratory Equipment; and $550,000 for Childrens Child Advocacy Centers.
Opposition to the Food and Drug Administration's proposed regulation for laboratory developed tests
H.R. 6585, the Bipartisan Workforce Pell Act, support workforce pell grant provisions and oppose section seven regarding agreements with applicable institutions.
Legislation to address funding shortfall in the Crime Victim Funds (CVF), including a proposed amendment to redirect funds from the False Claims Act to the CVF.
Duration: October 15, 2014
to
present
General Issues: Budget/Appropriations , Medical/Disease Research/Clinical Labs , Education , Law Enforcement/Crime/Criminal Justice , Health Issues , Medicare/Medicaid , Welfare , Insurance , Taxation/Internal Revenue Code
Spending: about $3,810,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: House of Representatives, U.S. Senate, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), White House Office, Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Office of the Vice President of the United States
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 21.
Original Filing: 301568976.xml
Lobbying Issues
Support for FY 2024 funding of: $738 million for the Childrens Hospital Graduate Medical Education (CHGME) Program; and strong funding levels for Healthy Start, Pediatric Specialty Loan Repayment Program; pediatric research at the NIH; CDC & NIH gun violence prevention research, and the Child Abuse Prevention and Treatment Act. Support for FY2025 of: $758 million for CHGME; $865,000 in community directed spending for Childrens Laboratory Equipment; and $550,000 for Childrens Child Advocacy Centers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposition to the Food and Drug Administration's proposed regulation for laboratory developed tests
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 6585, the Bipartisan Workforce Pell Act, support workforce pell grant provisions and oppose section seven regarding agreements with applicable institutions.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to address funding shortfall in the Crime Victim Funds (CVF), including a proposed amendment to redirect funds from the False Claims Act to the CVF.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2023
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 19.
Original Filing: 301531137.xml
Lobbying Issues
Advocated for FY 2024 program funding for: $738 million for the Childrens Hospital Graduate Medical Education Program; provide increased funding for the Victims of Crime Act through appropriations or authorization process to address projected FY24 cuts to state allocations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Amend PHSA to reauthorize the program of payments to children's hospitals that operate graduate medical education programs (H.R. 3841), support all provisions. Childrens Hospital GME Support Reauthorization Act of 2023, (H.R. 3887), oppose funding limitation language. Access to AEDs Act (H.R.2370, S.1024), support all provisions; Pediatric Specialty Loan Repayment Program, implementation; Bipartisan Primary Care and Health Workforce Act (S. 2840), oppose sections 302 & 303 and support reauthorization of workforce programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act of 2023 (S. 2345/H.R. 4714), support all provisions
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2023.
Original Filing: 301504861.xml
Lobbying Issues
Advocated for FY 2024 program funding for: $738 million for the Childrens Hospital Graduate Medical Education Program; $268 million for Community and Youth Violence Prevention at the CDC; Gun violence prevention research, including $35m for CDC and $25m for NIH, and $1m for National Institute of Justice (NIJ). Advocated for community project funding of $1M for mental & behavioral health access center; $30M for Pediatric Subspecialty Loan Repayment Program funding; and robust funding for Community-Based Child Abuse Prevention (CBCAP) grants.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Amend PHSA to reauthorize the program of payments to children's hospitals that operate graduate medical education programs (H.R. 3841), support all provisions. Childrens Hospital GME Support Reauthorization Act of 2023, (H.R. 3887), oppose funding limitation language. Access to AEDs Act (H.R.2370, S.1024), support all provisions; Pediatric Specialty Loan Repayment Program, implementation; Bipartisan Primary Care and Health Workforce Act (S. 2840), oppose sections 302 & 303 and support reauthorization of workforce programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act of 2023 (S. 2345/H.R. 4714), support all provisions; Life Saving Leave Act (HR 3024), support all provisions.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
support making permanent a state option to provide continuous eligibility for pregnant and postpartum individuals
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 19, 2023.
Original Filing: 301482941.xml
Lobbying Issues
Advocated for FY 2024 program funding for: $738 million for the Childrens Hospital Graduate Medical Education Program; $268 million for Community and Youth Violence Prevention at the CDC; Gun violence prevention research, including $35m for CDC and $25m for NIH, and $1m for National Institute of Justice (NIJ). Advocated for community project funding: $583, 400 for Project Ujima violence prevention initiative; $1.9 million for laboratory equipment to support pediatric research; $2M for mental & behavioral health access center; and $2.2M for health navigation pilot program; $30M for Pediatric Subspecialty Loan Repayment Program funding; and robust funding for Community-Based Child Abuse Prevention (CBCAP) grants
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Amend PHSA to reauthorize the program of payments to children's hospitals that operate graduate medical education programs (H.R. 3841), support all provisions. Childrens Hospital GME Support Reauthorization Act of 2023, (H.R. 3887), oppose funding limitation language. Access to AEDs Act (H.R.2370, S.1024), support all provisions; Perinatal Workforce Act (S.1710/H.R. 3523), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
RARE Act (S.1214), support all provisions
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
support making permanent a state option to provide continuous eligibility for pregnant and postpartum individuals
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301459245.xml
Lobbying Issues
Budget: Advocated for FY 2024 program funding for: $738 million for the Childrens Hospital Graduate Medical Education Program; $268 million for Community and Youth Violence Prevention at the CDC; Gun violence prevention research, including $35m for CDC and $25m for NIH, and $1m for National Institute of Justice (NIJ). Advocated for community project funding: $583, 400 for Project Ujima violence prevention initiative; $1.9 million for laboratory equipment to support pediatric research; $2M for mental & behavioral health access center; and $2.2M for health navigation pilot program.Requested robust funding for Community-Based Child Abuse Prevention (CBCAP) grants.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the Childrens Hospital Graduate Education Program (CHGME); support of the Food and Drug Administrations (FDA) proposals to prohibit the sale of menthol cigarettes and flavored cigars; support for investments in the pediatric workforce.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2023.
Original Filing: 301433700.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Health Care Capacity for Pediatric Mental Health Act (S. 4472), support all provisions; Kids Mental Health Now Act (S. 4747), support all provisions; Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666), support provisions to reauthorize the Community Mental Health Block Grant; Project AWARE, National Traumatic Stress Network, and Pediatric Health Care Access Grants; Jackie Walorski Maternal and Child Home Visiting Reauthorization Act (H.R. 8876), support all provisions);
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2023 funding of $718.8 million for the Childrens Hospital Graduate Medical Education Program.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policies to strengthen Medicaid and CHIP, including 12 months continuous eligibility for children and 12 months postpartum coverage and permanent reauthorization of the Childrens Health Insurance Program; Investing in Kids Mental Health Now Act (S. 474), support all provisions; Treatment Family Care Services Act (S. 3761), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Strengthen the Mental Health Parity and Addiction Equity Act of 2008 and adopt network adequacy standards to ensure that children and adolescents are not denied or delayed access to needed mental health services across the continuum of care including removing barriers to continuity of whole-person care such as providing integrated physical and mental health care
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act of 2021 or the PACT Act of 2021 (H.R. 3773/S.1357), support all provisions. Support provisions in the omnibus to improve treatments and care for children with rare diseases, including provisions to strengthen the FDAs accelerated approval pathway, clarify and codify the orphan drug exclusivity, and expand clinical trials. The VALID Act (H.R. 4128/S.2209), oppose provisions related to regulation of certain pediatric laboratory tests.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2022.
Original Filing: 301411592.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Health Care Capacity for Pediatric Mental Health Act (S. 4472), support all provisions; Kids Mental Health Now Act (S. 4747), support all provisions; Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666), support provisions to reauthorize the Community Mental Health Block Grant; Project AWARE, National Traumatic Stress Network, and Pediatric Health Care Access Grants; Jackie Walorski Maternal and Child Home Visiting Reauthorization Act (H.R. 8876), support all provisions); Assault Weapons Ban of 2022 (H.R. 1808), support all provisions; Break the Cycle of Violence Act (H.R. 4118), support provisions to establish an Office of Community Violence Intervention and support grants for community violence intervention initiatives.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2023 funding for the following programs: $718.8 million Childrens Hospital Graduate Medical Education Program; Request to not include provisions in annual appropriations bill that would weaken FDAs authority over tobacco products
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Increasing Medicaid funding for pediatric mental and behavioral health; Treatment Family Care Services Act (S. 3761), support all provisions. Prescription Digital Therapeutics (PDTs) Access Act (H.R. 7051), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act of 2021 (H.R. 3773/S.1357), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Strengthen the Mental Health Parity and Addiction Equity Act of 2008 and adopt network adequacy standards to ensure that children and adolescents are not denied or delayed access to needed mental health services across the continuum of care including removing barriers to continuity of whole-person care such as providing integrated physical and mental health care
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301388585.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Support for reauthorization of current federal mental health programs including, the Community Mental Health Block Grant; Project AWARE, National Traumatic Stress Network, and Pediatric Health Care Access Grants. Bipartisan Background Checks Act of 2021 (H.R. 8), support all provisions; Enhanced Background Checks Act of 2021 (H.R. 1446), support all provisions. Protecting Our Kids Act (H.R. 7910), support all provisions; Federal Extreme Risk Protection Order Act of 2021(H.R. 2377), support all provisions; Bipartisan Safer Communities Act (S.2938), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2023 funding for the following programs: $718.8 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; $60 million for CDC and NIH to conduct public health research into firearm morbidity and mortality prevention. Congressionally Directed FY2023 Spending and/or Community Funded Projects: $1 million for capital equipment for Childrens new EDTC; $876, 500 to expand access to Triple P parenting education; $365,00 to support expansion of integrated mental and behavioral health services; $250,000 for education and training to support local county child well-being initiative; and funding for Sojourner Truth House crisis housing facility.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Increasing Medicaid funding for pediatric mental and behavioral health; Treatment Family Care Services Act (S. 3761), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act of 2021 (H.R. 3773/S.1357), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Strengthen the Mental Health Parity and Addiction Equity Act of 2008 and adopt network adequacy standards to ensure that children and adolescents are not denied or delayed access to needed mental health services across the continuum of care including removing barriers to continuity of whole-person care such as providing integrated physical and mental health care
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 19, 2022.
Original Filing: 301363304.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Reauthorization of the Maternal, Infant, and Early Childhood Home Visiting Program (MIECHV); Improving access to mental and behavioral health of at-risk kids and those enrolled in the foster care system; Child Poverty Reduction Act (H.R. 1558/S. 643), support all provisions. Support for providing automatic Head Start eligibility for child welfare-involved children.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2022 funding for the following programs: $485 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; Congressionally Directed FY2022 Spending and/or Community Funded Projects: $400,000 for research laboratory equipment for Childrens Research Institute; $202,000 to enhance Project Ujimas violence prevention services; and $300,000 to expand school-based mental health services; $2.5 million for Milwaukee Countys Mental Health Emergency Center; $533,000 for Sojourner Family Peace Centers Crisis Outreach and Intervention in Neighborhoods Teams; Support for funding of pediatric mental health care programs including Project AWARE, National Traumatic Stress Network, and Pediatric Health Care Access Grants
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Increasing Medicaid funding for pediatric mental and behavioral health; Treatment Family Care Services Act (S. 3761), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for providing the FDA with ability to regulate synthetic nicotine to reduce use of e-cigarettes by youth; support for Strengthen the Mental Health Parity and Addiction Equity Act of 2008 and adopting pediatric network adequacy standards.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301327953.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Expanding access to kids mental health services through authorized federal funding; Crime Victims Fund Sustainability and VOCA Fix Act of 2021 (H.R. 1652, S.611), support all provisions; Providing access to pediatric COVID-19 vaccines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2022 funding for the following programs: $485 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; Congressionally Directed FY2022 Spending and/or Community Funded Projects: $400,000 for research laboratory equipment for Childrens Research Institute; $202,000 to enhance Project Ujimas violence prevention services; and $300,000 to expand school-based mental health services; $2.5 million for Milwaukee Countys Mental Health Emergency Center; $533,000 for Sojourner Family Peace Centers The Crisis Outreach and Intervention in Neighborhoods Teams. Build Back Better (H.R. 5376) in support of provisions to secure permanency in the Childrens Health Insurance Program; provide 12-month continuous eligibility for children covered by Medicaid & CHIP; provide $250 million for CHGME; and funding for initiatives to address childhood poverty, maternal health, pediatric mental health, violence prevention and lead poisoning prevention.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid: Accelerating Kids Access to Care Act (H.R. 3089/S.1544), support all provisions; Stabilize Medicaid and CHIP Coverage Act of 2021 (H.R. 1738, S. 646), support all provisions; Support for making permanent the state option to provide continuous eligibility for pregnant and postpartum individuals. Implementation of the ACE Kids Act, in support of Administrations development of out-of-state guidance & definition of medically complex children.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act H.R.3773/S.1357), support all provisions
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301305897.xml
Lobbying Issues
Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Crime Victims Fund Sustainability and VOCA Fix Act of 2021 (H.R. 1652, S.611), support all provisions. Resources to Prevent Youth Vaping Act (S. 2445), support all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2022 funding for the following programs: $485 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; Congressionally Directed FY2022 Spending and/or Community Funded Projects: $400,000 for research laboratory equipment for Childrens Research Institute; $202,000 to enhance Project Ujimas violence prevention services; and $300,000 to expand school-based mental health services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Accelerating Kids Access to Care Act (H.R. 3089/S.1544), support all provisions; Stabilize Medicaid and CHIP Coverage Act of 2021 (H.R. 1738, S. 646), support all provisions; Support for making permanent the state option to provide continuous eligibility for pregnant and postpartum individuals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pediatricians Accelerate Childhood Therapies Act H.R.3773/S.1357), support all provisions
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 19, 2021.
Original Filing: 301280205.xml
Lobbying Issues
Support for policies to improve access to mental health services for children, including: increasing federal Medicaid support for pediatric behavioral health; extending telehealth flexibilities; establishing a new designated pool of grant funding supporting pediatric behavioral health care integration; and dedicated funding for training of behavioral health workforce. Provide $5 billion in funding in the American Jobs Plans for Hospital violence intervention programs and other community violence intervention programs. Safe Cribs Act (S.1259), support all provisions; The Safe Sleep Act (H.R. 3182), support all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for FY 2022 funding for the following programs: $485 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; $50 Million Centers for Disease Control & Prevention (CDC) to conduct public health research into firearm morbidity and mortality; and $102.5 million for REACH Funding; Congressionally Directed FY2022 Spending and/or Community Funded Projects: $400,000 for research laboratory equipment for Childrens Research Institute; $438,000 for plain film (x-ray) machines for Childrens Forest Home Clinic; $200,000 to expand our school-based mental health services; $202,000 to enhance Project Ujimas violence prevention services; and $300,000 to expand school-based mental health services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Accelerating Kids Access to Care Act (H.R. 3089/S.1544), support all provisions; Support for making permanent the state option in Medicaid to provide continuous eligibility for pregnant and postpartum individuals;
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301260310.xml
Lobbying Issues
Bipartisan Background Checks Act of 2021 (H.R. 8), support all provisions; the Enhance Background Checks Act of 2021 (H.R. 1446), support all provisions; Bipartisan Solution to Cyclical Violence Act (H.R. 1260), support all provisions; VOCA Fix to Sustain the Crime Victims Fund Act of 2021 (S. 611) support all provisions; Child Poverty Reduction Act (S. 643), support all provisions; Rescind the public charge rule regulation
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2022 funding for the following programs: $485 million Childrens Hospital Graduate Medical Education Program,$50 million for the Pediatric Loan Specialty Program; $50 Million Centers for Disease Control & Prevention (CDC) to conduct public health research into firearm morbidity and mortality; and $102.5 million in the FY 2022 Labor, Health and Human Services, and Education Appropriations bill for REACH. American Rescue Plan Act (H.R.139), support for provisions to direct funding to pediatric behavioral and mental health services, expand subsidies for Marketplace plans, direct resources to states, communities and schools to combat COVID-19; enhance FMAP for Medicaid, and funding to programs to support vulnerable children and family, such as food and housing assistance. Support for CARES Provider Relief funding to high-Medicaid providers, including childrens hospitals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Strengthening the Vaccines for Children Program Act of 2021, support all provisions
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301236190.xml
Lobbying Issues
Scarlett's Sunshine on Sudden Unexpected Death Act (H.R.2271), support all provisions. Request for formula changes to the Crime Victims Fund (CVF) to account for lower deposits in recent year in order to prevent cuts to the Victims of Crime Act grant program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2021 funding for the Childrens Hospital Graduate Medical Education Program at a level of $465 million; Support in COVID-19 relief bill for increased funding for the following: pediatric behavioral and mental health services; personal protective equipment for essential workers and communities disproportionally impacted by COVID-19; and testing and other resources needed by states, communities and schools to combat the virus. Request to Department of Health and Human Services to revert to June reporting guidance for purposes of CARES provider relief funds.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support for adoption of MACPACs recommended legislative language related to 3rd Party Medicaid DSH payments; Support for extension of Medicare telehealth waivers, specifically related to originating site and audio only for behavioral health; Support for extension of the increased Federal Medicaid Assistance Percentage (FMAP) as a result of COVID-19
Agencies Lobbied
U.S. Senate
Lobbying Issues
No Surprises Act (H.R. 3630), provisions related to consolidation of professional and facility claims, support for billing only for employed providers, and timeline for bills, changes to account for patients with secondary insurance coverage. Request that the Administration enforce current law related to the 340B program and utilization of contract pharmacies
Agencies Lobbied
Health & Human Services - Dept of (HHS)
3rd Quarter, 2020
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2020.
Original Filing: 301215906.xml
Lobbying Issues
Scarlett's Sunshine on Sudden Unexpected Death Act (H.R.2271), support all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2021 funding for the Childrens Hospital Graduate Medical Education Program at a level of $465 million; Support for additional funding for the Childrens Hospital Graduate Medical Education Program in COVID-19 relief bill. Support for an allocation of $2 billion in funding from the Public Health and Social Services Emergency Fund for childrens hospitals to support increased expenses and lost revenue as a result of COVID-19. Support for increase funding for pediatric behavioral and mental health services. Request for Department of Health and Human Services (HHS) to reinstate June provider relief reporting guidance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support for adoption of MACPACs recommended legislative language related to 3rd Party Medicaid DSH payments; Support for delay of implementation of the Medicaid Fiscal Accountability Rule; Support for extension of Medicare telehealth waivers, specifically related to originating site and audio only for behavioral health; Support for extension of the increased Federal Medicaid Assistance Percentage (FMAP) to support states' response to COVID-19.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Request for Department of Health and Human Services to provide an extended open enrollment period for the federal health insurance exchange;Request that the Administration enforce current law related to the 340B program and utilization of contract pharmacies.
Agencies Lobbied
Health & Human Services - Dept of (HHS)
2nd Quarter, 2020
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 16, 2020.
Original Filing: 301190104.xml
Lobbying Issues
Support for inclusion of funding for child welfare in legislation to address the pandemic, including FMAP rates increased in Title IV-E, increase funding for CAPTA Title I by $500 million; Dosha Joi Immediate Coverage for Foster Youth Act (H.R. 6959), support all provisions. SHOP Safe Act of 2020 (H.R. 6058) support for provisions related to preventing counterfeit car seats.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Paycheck Protection Program and Health Care Enhancement Act (H.R. 266), support for provisions related to COVID-19 testing and surveillance and the Public Health and Social Services Emergency Fund; Support for funding from the Public Health and Social Services Emergency Fund for childrens hospitals;funding for pediatric behavioral and mental health services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support for adoption of MACPACs recommended legislative language related to 3rd Party Medicaid DSH payments; Support for delay of implementation of the Medicaid Fiscal Accountability Rule; Support for extension of Medicare telehealth waivers, specifically related to originating site and audio only for behavioral health.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 19, 2020.
Original Filing: 301172169.xml
Lobbying Issues
Support for inclusion of funding for the Maternal, Infant, and Early Childhood Home Visiting program and child welfare in legislation to address the pandemic.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the following programs in the fiscal year 2021 Labor Health and Human Services, Education and Related Agencies: $465 million for the for the Children's Hospital Graduate Medical Education; $10 million for the Pediatric Mental Health Access Program; $50 million in funding for the Centers for Disease Control and Prevention to conduct public health research into firearm morbidity and mortality prevention; $22.334 million for the Emergency Medical Services for Children Program; $20 million for the Pediatric Disaster Care Pilot Program.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Coronavirus Aid, Relief, and Economic Security (H.R.6074), support for provisions related to the Public Health and Services Emergency Fund, hospital preparedness & personal protective equipment, mental health grants, and state stabilization funding; Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339), support all provisions; Resources to Prevent Youth Vaping Act (S. 3233), support all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for adoption of MACPACs recommended legislative language related to 3rd Party Medicaid Disproportionate Share Payments; Support for delay of implementation of the Medicaid Fiscal Accountability Rule; Families First Coronavirus Response Act (H.R. 6201), support for provision related to the increased in the Medicaid Federal Matching Assistance Percentage; support for Medicaid national collaborative on pediatric mental health.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 17, 2020.
Original Filing: 301108369.xml
Lobbying Issues
Reauthorization of the Child Abuse Prevention and Treatment Act related to increasing focus on community-based prevention programs and addressing sentinel injuries in infants; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (S.1009), all provisions; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (H.R. 2076), all provisions; RISE from Trauma Act (H.R. 3180), all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the following programs in the fiscal year 2020 Labor Health and Human Services, Education and Related Agencies: $400 million for the for the Children's Hospital Graduate Medical Education; $10 million for the Pediatric Mental Health Access Program; and; $50 million in funding for the Centers for Disease Control and Prevention to conduct public health research into firearm morbidity and mortality prevention.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Mental Health Services for Students Act (H.R. 1109), all provisions; Mental Health Services for Students Act (S. 1122), all provisions; Lower Health Care Costs Act (S.1895), provisions related to surprise medical bills and benchmark rate, hospital transparency provisions and public health improvements; No Surprises Act of 2019 (H.R. 3630) provisions related to surprise medical bills and benchmark rate; National Suicide Hotline Designation Act (S.2661), all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
The Protect Access to Cellular Transplant Act (H.R. 2498), all provisions; The Protect Access to Cellular Transplant Act (S. 1286), all provisions; The Advancing Access to Precision Medicine Act (H.R. 4393), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339), all provisions; Support of Administrations proposed action to remove all flavored e-cigarette products from the market; Support of raising the minimum purchase price of all tobacco products to age 21 included in FY 2020 omnibus appropriations bill .
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2019.
Original Filing: 301069948.xml
Lobbying Issues
Stronger Child Abuse Prevention and Treatment Act (H.R. 2480), all provisions; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (S.1009), all provisions; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (H.R. 2076), all provisions; RISE from Trauma Act (H.R. 3180), all provisions; Support for policies that protect the health and well-being of children at the southern border. Support for legislation to keep kids safe from violence, including policies to improve background checks for firearm sales and ensure safeguards are in place for access to and use of automatic weapons and high capacity magazines.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the following programs in the fiscal year 2020 Labor Health and Human Services, Education and Related Agencies: $400 million for the for the Children's Hospital Graduate Medical Education; $10 million for the Pediatric Mental Health Access Program; and; $50 million in funding for the Centers for Disease Control and Prevention to conduct public health research into firearm morbidity and mortality prevention.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Mental Health Services for Students Act (H.R. 1109), all provisions; Mental Health Services for Students Act (S. 1122), all provisions; Lower Health Care Costs Act (S.1895), provisions related to surprise medical bills and benchmark rate, hospital transparency provisions and public health improvements; No Surprises Act of 2019 (H.R. 3630) provisions related to surprise medical bills and benchmark rate.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 19, 2019.
Original Filing: 301050797.xml
Lobbying Issues
Protecting Jessica Grubb's Legacy Act (S.1012), provisions related to HIPPA and 42CFR; Overdose Prevention and Patient Safety Act (H.R. 2062), provisions related to HIPPA and 42CFR.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Re-authorization of the Child Abuse Prevention and Treatment Act related to increasing focus on community-based prevention programs and addressing sentinel injuries in infants; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (S.1009), all provisions; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (H.R. 2076), all provisions; Treatment Family Care Services Act (S. 1880), all provisions; RISE from Trauma Act (H.R. 3180), all provisions; Support for policies that protect the health and well-being of children at the southern border.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the following programs in the fiscal year 2020 Labor Health and Human Services, Education and Related Agencies: $400 million for the for the Children's Hospital Graduate Medical Education; $10 million for the Pediatric Mental Health Access Program;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Mental Health Services for Students Act (H.R. 1109), all provisions; Mental Health Services for Students Act (S. 1122), all provisions; Lower Health Care Costs Act (S.1895), provisions related to surprise medical bills, transparency and public health improvements; Poison Center Network Enhancement Act of 2019 (S. 1199), all provisions, Emergency Medical Services for Children Reauthorization Act, (S.1173), all provisions.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 16, 2019.
Original Filing: 301026067.xml
Lobbying Issues
General support for the Medicaid program and impact on children's health; Accelerating Kids' Access to Care Act (S. 317), all provisions; The ACE Kids Act (H.R.1226), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of the Child Abuse Prevention and Treatment Act related to increasing focus on community-based prevention programs and addressing sentinel injuries in infants; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (S.1009), all provisions; Early Detection to Stop Infant Abuse and Prevent Fatalities Act (H.R. 2076), all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the following programs in the fiscal year 2020 Labor Health and Human Services, Education and Related Agencies: $400 million for the for the Children's Hospital Graduate Medical Education; $10 million for the Pediatric Mental Health Access Program; $50 million in funding for the Centers for Disease Control and Prevention to conduct public health research into firearm morbidity and mortality prevention. Advocated for language to be included in the House & Senate Labor, HHS, Education and Related Agencies report that would direct the National Institutes of Health to build upon the formation of the Trans-NIH Pediatric Research Consortium to develop a framework for a pediatric research training mechanism
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 21, 2019.
Original Filing: 301011624.xml
Lobbying Issues
General support for the Medicaid program; Accelerating Kids' Access to Care Act (S. 2415), all provisions; The ACE Kids Act (H.R. 3325, S. 428), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the Family First Prevention and Services Act (P.L. 115-123);
Agencies Lobbied
U.S. Senate
Lobbying Issues
340B Drug Program, protecting eligibility for childrens hospitals. Emergency Medical Services for Children Program Reauthorization Act of 2018 (H.R 6748, S. 3402), all provisions;
Scarletts Sunshine on Sudden Unexpected Death Act (H.R. 6931), all provisions.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2018.
Original Filing: 300987222.xml
Lobbying Issues
Childrens Hospital GME Support (H.R. 5385), all provisions; Childrens GME Support Reauthorization Act (S. 2597), all provisions; General support for the Medicaid program an coverage of children and families; Accelerating Kids' Access to Care Act (S. 2415), all provisions; The ACE Kids Act (H.R. 3325, S. 428), all provisions. These bills would improve access to out-of-state care for children enrolled in Medicaid and allow for the creation of medical homes for children with complex medical conditions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for Patients and Communities (H.R 6), provisions related to prevention with highrisk families early, ACEs and promoting the utilization of traumainformed, strengthsbased approaches.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $330 million for FY2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
340B Drug Program, protecting eligibility for childrens hospitals. Emergency Medical Services for Children Program Reauthorization Act of 2018 (H.R 6748, S. 3402), all provisions. This bill provides support for efforts to reduce child and youth mortality from severe illness or trauma. Scarletts Sunshine on Sudden Unexpected Death Act (H.R. 6931), all provisions. H.R. 6931 seeks to raise awareness and authorize resources for strategies aimed at reducing unexpected infant and child deaths.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 18, 2018.
Original Filing: 300967831.xml
Lobbying Issues
Childrens Hospital GME Support (H.R. 5385), all provisions; Childrens GME Support Reauthorization Act (S. 2597), all provisions. General support for the Medicaid program. Accelerating Kids' Access to Care Act (S. 2415), all provisions. The Spending Cuts to Expired and Unnecessary Programs Act (H.R. 3), opposed to changes in CHIP spending.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Keeping kids separated at border with their family; Opioid Crisis Response Act of 2018 (S.2680), provisions related to prevention with highrisk families early, ACEs and promoting the utilization of traumainformed, strengthsbased approaches.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million for FY2018 and $330 million for FY2019;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provisions related to stabilizing the Marketplace Exchange. 340B Drug Program, protecting eligibility for childrens hospitals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 17, 2018.
Original Filing: 300946248.xml
Lobbying Issues
Keeping Kids Insurance Dependable and Secure (KIDS) Act (S.1827), all provisions; Championing Healthy Kids Act (H.R.3922), all provisions. Childrens Health Insurance Program, continuation of funding for FY2018 and beyond.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Establishment of a pediatric program office or coordinating council at the National Institutes of Health.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Increasing Opportunity and Success for Children and Parents through Evidence-Based Home Visiting Act (H.R.2824), all provisions. Strong Families Act of 2017 (S.1829), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million for FY2018 and $330 million for FY2019; Budget Control Act of 2018 (H.R.1892), relating to provisions extending the Childrens Health Insurance Program, Maternal, Infant, and Early Childhood Home Visiting program and authorizing the Family First Prevention Services Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provisions related to stabilizing the Marketplace Exchange, including continuation of Cost Sharing Reductions and establishment of a federal reinsurance program.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 18, 2018.
Original Filing: 300926114.xml
Lobbying Issues
Keeping Kids Insurance Dependable and Secure (KIDS) Act (S.1827), all provisions; Championing Healthy Kids Act (H.R.3922), all provisions. Childrens Health Insurance Program, continuation of funding for FY2018 and beyond.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Establishment of a pediatric program office or coordinating council at the National Institutes of Health.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Increasing Opportunity and Success for Children and Parents through Evidence-Based Home Visiting Act (H.R.2824), all provisions. Strong Families Act of 2017 (S.1829), all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Cuts and Jobs Act (H.R.1), provisions relate to repealing the tax exempt and advanced refunding for nonprofits, expansion of the standard deduction, maintaining the charitable deduction, and repeal of the individual mandate.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2017.
Original Filing: 300906608.xml
Lobbying Issues
Medicaid, ensuring children continue to have access to current coverage and benefits; all provisions; Better Care Reconciliation Act (H.R. 1628), all provisions. Graham-Cassidy legislation to repeal and replace the Affordable Care Act, all provisions. Childrens Health Insurance Program, continuation of funding for FY2018 and beyond.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Continuation of cost sharing reductions payment for Marketplace.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Increasing Opportunity and Success for Children and Parents through Evidence-Based Home Visiting Act (H.R.2824), all provisions. Strong Families Act of 2017 (S.1829), all provisions. Family-Based Care Services Act (S.1357), all provisions
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 18, 2017.
Original Filing: 300888012.xml
Lobbying Issues
Medicaid, ensuring children continue to have access to current coverage and benefits; American Health Care Act (H.R .1628), all provisions; Better Care Reconciliation Act (H.R. 1628), all provisions. Childrens Health Insurance Program, continuation of funding for FY2018 and beyond.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for Environmental Protection Agencys lead paint program at current levels; Maintain Food and Drug Administration (FDA) to oversee tobacco products in fiscal year 2018 FDA appropriations bill. Continuation of cost sharing reductions payment for Marketplace.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
The Maternal, Infant, and Early Childhood Home Visiting program, reauthorization of the program.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 13, 2017.
Original Filing: 300865209.xml
Lobbying Issues
Medicaid, ensuring children continue to have access to current coverage and benefits; American Health Care Act (H.R .1628), all provisions; Childrens Health Insurance Program, continuation of funding for FY2018 and beyond.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the Centers for Disease Control and Prevention Programs at no less than $7.8 billion.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the 21st Century Cures Act, provisions related to pediatric training and research
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
The Maternal, Infant, and Early Childhood Home Visiting program, reauthorization of the program.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 13, 2017.
Original Filing: 300845918.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Medicaid reform, ensuring coverage for children.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Senate Amendment to H.R. 34, H.R. 21st Century Cures Act, provisions related to pediatric medical research and mental health;Implementation of the National Research Pediatric Research Act; Administrations Cancer Moonshot initiative, ensure appropriate representation of pediatric issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 5454, Family First Prevention Services Act of 2016, title I regarding prevention services; S.3065, Family First Prevention Services Act of 2016, title I regarding prevention services; S.420, Family-Based Foster Care Services Act, all provisions
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2016.
Original Filing: 300832958.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Policies to improve and streamline Medicaid credentialing for out-of-state pediatric providers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group; funding for the Centers for Disease Services state tobacco control and quitline
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; Administrations Cancer Moonshot initiative, ensure appropriate representation of pediatric issues; H.R. 4616 Living Donor Act Protection Act, all provisions; S.2584 Living Donor Act Protection Act, all provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 5454, Family First Prevention Services Act of 2016, title I regarding prevention services; S.3065, Family First Prevention Services Act of 2016, title I regarding prevention services; S.420, Family-Based Foster Care Services Act, all provisions
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 13, 2016.
Original Filing: 300808886.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Policies to improve and streamline Medicaid credentialing for out-of-state pediatric providers
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 340B Program, continuation of eligibility for childrens hospitals; Mental Health Reform Act of 2016, section 503 telehealth child psychiatry access program; Administrations Cancer Moonshot initiative, ensure appropriate representation of pediatric issues. S. 2508, Youth Sports Concussions Act, all provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 5454, Family First Prevention Services Act of 2016, title I regarding prevention services; S.3065, Family First Prevention Services Act of 2016, title I regarding prevention services; S.420, Family-Based Foster Care Services Act, all provisions;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Victims of Child Abuse Act and Victims of Crime Act, appropriations for child advocacy and abuse services.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2016
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 19, 2016.
Original Filing: 300794267.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Medicaid financing related to pediatric population and access to dental services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group; 340G of Public Service Act, funding for innovation grants to improve access to dental services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 340B Program, continuation of eligibility for childrens hospitals; H.R. 3381, The Childhood Cancer Survivorship Treatment, Access and Research Act, all provisions; S.1883, The Childhood Cancer Survivorship Treatment, Access and Research Act, all provisions; Mental Health Reform Act of 2016, section 503 telehealth child psychiatry access program; Administrations Cancer Moonshot initiative, ensure appropriate representation of pediatric issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S.1964,The Family & Stability Kinship Care Act, all provisions; S.1932, All Kids Matter Act, all provisions; S.420, Family-Based Foster Care Services Act, all provisions; Families First Act, draft proposal in the Senate, all provisions; H.R. 4571, The Reducing Unexpected Deaths in Infants and Children Act of 2016, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Victims of Child Abuse Act, appropriations for child advocacy and abuse services.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2015
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 14, 2016.
Original Filing: 300771996.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Medicaid financing related to pediatric population.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 340B Program, continuation of eligibility for childrens hospitals; H.R. 3381, The Childhood Cancer Survivorship Treatment, Access and Research Act, all provisions; S.1883, The Childhood Cancer Survivorship Treatment, Access and Research Act, all provisions.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S.1964,The Family & Stability Kinship Care Act, all provisions; S.1932, All Kids Matter Act, all provisions; S.420, Family-Based Foster Care Services Act, all provisions; H.R. 576, Homeless Children and Youth Act, all provisions; S.256 Homeless Children and Youth Act, all provisions. S.2224, Child Poverty Reduction Act, all provisions; S.2267 Higher Education Access and Success for Homeless and Foster Youth Act of 2015, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Justice Appropriations, Grants to Encourage Arrests Policies Program, prioritizing funding for family justice centers that provide services to child and adult victims of violence; Victims of Child Abuse Act, appropriations.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2015
In Q3, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2015.
Original Filing: 300756340.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Medicaid financing related to pediatric population.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 21st Century Cures Act, provisions related to the National Research Pediatric Research Act; 340B Program, continuation of eligibility for childrens hospitals; H.R. 3381, The Childhood Cancer Survivorship Treatment, Access and Research Act; S.1883, The Childhood Cancer Survivorship Treatment, Access and Research Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S.1964,The Family and Stability Kinship Care Act, all provisions; S.1932, All Kids Matter Act, all provisions; S.420, Family-Based Foster Care Services Act, all provisions; H.R. 576, Homeless Children and Youth Act, all provisions; S.256 Homeless Children and Youth Act, all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
Department of Justice Appropriations, Grants to Encourage Arrests Policies Program, prioritizing funding for family justice centers that provide services to child and adult victims of violence; Victims of Child Abuse Act, appropriations.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2015
In Q2, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on July 13, 2015.
Original Filing: 300733490.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; Medicaid financing related to pediatric population.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group;H.R. 282, Long-Term Studies of Comprehensive Outcomes and Returns for the Economy Score Act, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 21st Century Cures Act, provisions related to the National Research Pediatric Research Act; 340B Program, continuation of eligibility for childrens hospitals.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Title IV-E financing and policies related to foster care programs; Family Services and Foster Care discussion draft, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.178, Justice for Victims of Trafficking Act, provisions related to authorizing resources to child advocacy centers; Department of Justice Appropriations, Grants to Encourage Arrests Policies Program, prioritizing funding for family justice centers that provide services to child and adult victims of violence; Victims of Child Abuse Act, appropriations.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2015
In Q1, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on April 16, 2015.
Original Filing: 300717459.xml
Lobbying Issues
H.R. 546, Advancing Care for Exceptional Kids Act of 2015, all provisions; S.298, Advancing Care for Exceptional Kids Act of 2015, all provisions; H.R. 2, Medicare Access and CHIP Reauthorization Act, Title II extension of the Childrens Health Insurance Program and Sec.218 Maternal Infant and Early Childhood Home Visiting Program; H.R. 700, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions; S.428, Stabilize Medicaid and CHIP Continuous Enrollment Act of 2015, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Funding for the Childrens Hospital Graduate Medical Education Act at the programs authorized level of $300 million; Funding for the National Institutes of Health, National Cancer Institute and Childrens Oncology Group.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Research Pediatric Research Act, all provisions; 21st Century Cures Act, provisions related to the National Research Pediatric Research Act and ACE Kids Act; 340B Program, continuation of eligibility for childrens hospitals
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Title IV-E financing and policies related to foster care programs; S.420, Family-Based Foster Care Services Act, all provisions
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.178, Justice for Victims of Trafficking Act, provisions related to authorizing resources to child advocacy centers; Department of Justice Appropriations, Grants to Encourage Arrests Policies Program, prioritizing funding for family justice centers that provide services to child and adult victims of violence.
Agencies Lobbied
U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2014
In Q4, Children's Hospital and Health System, Inc. had in-house lobbyists. The report was filed on Jan. 16, 2015.
Original Filing: 300697883.xml
Lobbying Issues
H.R. 4930, the Advancing Care for Exceptional Kids Act of 2014, all provisions; Extension of sec.1202 (Payments to Primary Care Physicians) of the Affordable Care Act, regarding payment for primary care services provided by qualifying physicians under Medicaid;H.R. 1698, the Stabilize Medicaid and CHIP Coverage Act, all provisions; S. 1980, the Medicaid and CHIP Continuous Quality Act, all provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Childrens Health Insurance Program, extension of funding and quality provisions through 2019;S.2966, Critical Care Assessment and Improvement Act, all provisions; Maternal, Infant, and Early Childhood Home Visiting Program, reauthorization of funding at current annual funding level.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 83, Making consolidated appropriations for the fiscal year ending September 30, 2015, and for other purposes, Division G, Title II regarding Department of Health and Human Services funding opportunities for Childrens Hospitals Graduate Medical Education, National Institutes of Health, Health Resources and Services Administration. Division G, Title II all provisions related to funding for maternal and child health services and foster care. Division G, Title VI Ebola Response and Preparedness, provisions related to support for training of medical personnel and preparedness of treatment facilities. Division B, Title II, funding of Victims of Crime Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of the National Pediatric Research Act, all provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
Children's Hospital and Health System, Inc. filed a lobbying registration on Oct. 30, 2014 for in-house lobbying efforts, effective Oct. 15, 2014.
Original Filing: 300690380.xml
Issue(s) they said they’d lobby about: Children's Health Insurance Program; Pediatric issues in health care reform implementation; 340B Program; Children's Hospitals Graduate Medical Education Payment Program; Medicaid and CHIP coverage and payment; Pediatric research issues and funding; H.R. 4930, ACE Kids Act all provisions; H.R.1698, Stabilize Medicaid and CHIP Act, all provisions; S.1980, Medicaid and CHIP Continuous Quality Act, all provisions; policy related to child welfare, access to health care, and child well-being .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...